Tower Research Capital (TRC)’s Quipt Home Medical QIPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-26
Closed -$92 – 5478
2025
Q4
$92 Buy
+26
New +$69 ﹤0.01% 5048
2025
Q3
– Sell
-14,125
Closed -$25.3K – 5546
2025
Q2
$25.3K Buy
14,125
+9,819
+228% +$19.4K ﹤0.01% 3534
2025
Q1
$10K Sell
4,306
-3,297
-43% -$9.04K ﹤0.01% 3685
2024
Q4
$23.2K Buy
7,603
+3,443
+83% +$9.27K ﹤0.01% 3078
2024
Q3
$12.1K Sell
4,160
-2,578
-38% -$7.96K ﹤0.01% 3614
2024
Q2
$21.7K Buy
6,738
+6,172
+1,090% +$22.1K ﹤0.01% 3713
2024
Q1
$2.47K Sell
566
-6,189
-92% -$28K ﹤0.01% 5032
2023
Q4
$34.4K Buy
6,755
+3,956
+141% +$18.9K ﹤0.01% 3348
2023
Q3
$14.2K Buy
2,799
+1,572
+128% +$8.43K ﹤0.01% 3697
2023
Q2
$6.55K Buy
+1,227
New +$7.24K ﹤0.01% 4686

Tower Research Capital (TRC)'s QIPT Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 26 shares — an estimated $92 sold.

Tower Research Capital (TRC) first reported a position in QIPT in Q2 2023 and held it in 10 quarters. The position peaked at $34.4K in Q4 2023. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 26 Quipt Home Medical shares in Q1 2026, an estimated $92.
  • Tower Research Capital (TRC) first reported a position in Quipt Home Medical in Q2 2023 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Quipt Home Medical position peaked at $34.4K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.